Acadia gets court approval related to Nuplazid patent
by
Contributor since / Followers
Contributor since / Followers
1 month ago
AndreyPopov/iStock via Getty Images Acadia Pharmaceuticals (NASDAQ:ACAD) said on Monday that the U.S. Court of
ACAD
Acadia Pharmaceuticals jumps after win in patent suit over Nuplazid
by
Contributor since / Followers
Contributor since / Followers
2 months ago
wildpixel/iStock via Getty Images Acadia Pharmaceuticals (NASDAQ:ACAD) soared 20% after a court ruling in patent
Acadia Pharmaceuticals files to sell 43.58M shares of common stock for holders
by
Contributor since / Followers
Contributor since / Followers
2 months ago
Acadia Pharmaceuticals (NASDAQ:ACAD) files a prospectus for the offer and sale of 43.6M shares of
Acad projects $244.3M Q1 revenue with DAYBUE and NUPLAZID growth, anticipates accelerated Prader-Willi trial data
by
Contributor since / Followers
Contributor since / Followers
2 months ago
Earnings Call Insights: ACADIA Pharmaceuticals Inc. (ACAD) Q1 2025 Management View CEO Catherine Owen Adams
Acadia Pharma GAAP EPS of $0.11 beats by $0.02, revenue of $244.3M beats by $5.33M
by
Contributor since / Followers
Contributor since / Followers
2 months ago
Acadia Pharma press release (NASDAQ:ACAD): Q1 GAAP EPS of $0.11 beats by $0.02. Revenue of
Acadia Pharma Q1 2025 Earnings Preview
by
Contributor since / Followers
Contributor since / Followers
2 months ago
Acadia Pharma (NASDAQ:ACAD) is scheduled to announce Q1 earnings results on Wednesday, May 7th, after
Acadia Pharma GAAP EPS of $0.86 beats by $0.63, revenue of $259.6M misses by $13.44M
by
Contributor since / Followers
Contributor since / Followers
5 months ago
Acadia Pharma press release (NASDAQ:ACAD): Q4 GAAP EPS of $0.86 beats by $0.63. Revenue of
Acadia Pharma Q4 2024 Earnings Preview
by
Contributor since / Followers
Contributor since / Followers
5 months ago
Acadia Pharma (NASDAQ:ACAD) is scheduled to announce Q4 earnings results on Wednesday, February 26th, after
Acadia expects more than $1B in sales for 2025
by
Contributor since / Followers
Contributor since / Followers
6 months ago
akinbostanci/iStock via Getty Images Acadia Pharmaceuticals (NASDAQ:ACAD) said that it expects to bring in product
Biggest stock movers Tuesday: VSTM, ACAD
by
Contributor since / Followers
Contributor since / Followers
6 months ago
Monty Rakusen On the final trading day of 2024, US stock futures were mainly lower